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INTRODUCTION
Multidrug resistance (MDR) is the main cause of failure in 
chemotherapy of cancer patients. Although MDR is a multifacto‑
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ABSTRACT
Multidrug resistance (MDR) is the main cause of failure in the chemotherapy of cancer patients. The present study aimed to evaluate 
the effects of sesquiterpene coumarins of Ferula gummosa fruits on P‑glycoprotein (P‑gp)–mediated MDR. Drimane‑type sesquiterpene 
coumarins from the fruits of F. gummosa were extracted with dichloromethane and subjected to column chromatography. The effects of 
the isolated compounds on P‑gp–mediated MDR were evaluated in the breast cancer cell line MCF‑7 which shows high resistance to 
doxoribicin (MCF‑7/Dox). Phytochemical investigation of dichloromethane extract of F. gummosa fruits resulted in three sesquiterpene 
coumarins including conferone (1), mogoltacin (2), and feselol (3). The structures of these compounds were confirmed by 1D and 2D 
Nuclear Magnetic Resonance (NMR) spectroscopy. Exposure of cells to conferone, mogoltacin, feselol, and verapamil (positive control) 
enhanced doxorubicin uptake by MCF‑7/Dox cells. This effect was dose dependent, but varied with the structure of the chemical. At 
25 μM, all the tested sesquiterpene coumarins restored at least 50% of the reference uptake (uptake by sensitive cells); but at 10 μM, 
their potency varied where conferone showed the highest potency and feselol showed the lowest potency. Conferone, mogoltacin, and 
feselol from F. gummosa suppress P‑gp–mediated drug efflux in highly resistant human breast cancer cells.
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rial phenomenon, its predominant cause is the overexpression 
of membrane transporter proteins belonging to the ATP‑binding 
cassette superfamily, namely P‑glycoprotein (P‑gp; ABCB1) and 
multidrug resistance protein (MRP1 or ABCC1).[1,2]
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The observation that many compounds of natural origin 
are capable of modulating MDR proteins has called increasing 
attention to these substances. Recent reports have demonstrated 
that sesquiterpene coumarins, which contain drimane‑type struc‑
ture in the sesquiterpene moiety, reverse P‑gp–mediated resistance 
considerably.[3,4] This class of natural compounds has been espe‑
cially reported from the genus Ferula (Apiaceae).[5] Many bioac‑
tive compounds have been reported from Ferula species,[6‑9] but 
the biological activities of drimane‑type sesquiterpene coumarins 
have poorly been documented.[3,4,10]
Objectives
In the present work, we isolated the sesquiterpene coumarins 
of Ferula gummosa fruits and evaluated the effects of three of 
them (conferone, mogoltacin, and feselol) on P‑gp–mediated MDR 
in the breast cancer cell line MCF‑7 which shows high resistance 
to doxorubicin (MCF‑7/Dox). The tested compounds belong to 
drimane‑type sesquiterpene coumarins.
MATERIALS AND METHODS
Plant material
Fruits of F. gummosa were collected from Hezar Masjed 
Mountains, northeast of Iran, in August 2005 and identified by 
Mohammadreza Joharchi at the Ferdowsi University of Mashhad 
Herbarium (FUMH). A voucher specimen (1002) was deposited 
at the herbarium of the Department of Pharmacognosy, School of 
Pharmacy, Mashhad University of Medical Sciences.
General experimental procedures
The 1H, gradient COrrelation SpectroscopY (gCOSY), Rotat‑
ing‑frame Overhauser Effect SpectroscopY (ROESY), gradient Het‑
eronuclear Single Quantum Coherence (gHSQC), and gradient Het‑
eronuclear Multiple Bond Coherence (gHMBC) Nuclear Magnetic 
Resonance (NMR) experiments were run under standard conditions 
on Bruker DRX‑500 and DRX‑600 spectrometers at 300 K. NMR 
samples were prepared by dissolving each sample in CDCl3 (99.8% 
D) (Carlo Erba, Italy). The spectra were calibrated using the solvent 
signal as the internal standard (1H, d: 7.27 ppm; 13C, d: 77.0 ppm). The 
ROESY spectra were obtained with a mixing time of 400 ms. The 
NMR data were processed on a Silicon Graphic Indigo2 Workstation 
using UXNMR software. Column chromatography was conducted 
with silica gel 230‑400 mesh (Merck, Germany).
Extraction and isolation
The air‑dried fruits (500 g) were ground into powder, defatted 
by petroleum ether, and extracted exhaustively by maceration with 
dichloromethane at room temperature. After filtration, the extract 
was concentrated under vacuum to yield 20 g of a brown residue.
A part of the extract (15 g) was subjected to column chro‑
matography on silica gel (5 × 50 cm) using petroleum ether with 
increasing volumes of acetone in a gradient system. The fractions 
were compared by thin layer chromatography (TLC; silica gel 
using petrol–Me2CO as solvent), and those giving similar spots 
were combined. Five fractions were finally obtained. Fractions 
1‑3 gave compounds 1 (15 mg), 2 (770 mg), and 3 (48.5 mg) as 
white crystals, respectively.[11]
Cell line and P-gp inhibition assay
Resistant MCF‑7/Dox cells were generated by one year of 
continuous exposure of sensitive MCF‑7 cells (European Col‑
lection of Cell Cultures, Salibury, UK) to Dox. These cells have 
been shown to overexpress P‑gp. Based on a previously described 
procedure,[12] cells were cultured as monolayers in 75‑cm2 culture 
flasks in Eagle’s minimum essential medium (Gibco‑BRL, Paisley, 
Scotland) supplemented with 10% fetal calf serum (FCS; Bio West, 
Nuaille’, France), vitamins, amino acids, and gentamycin (all from 
Gibco™, Invitrogen, Cergy‑Pontoise, France). The medium was 
changed every 48 h and subcultured with 5X trypsin/ethylene‑
diaminetetraacetic acid (EDTA) (Gibco). Cells were maintained 
at 37°C under a humidified atmosphere containing 5% CO2. The 
chemicals were obtained from Sigma, USA.
Cytotoxicity was assessed using the colorimetric 3‑(4,5‑dimeth‑
ylthiazol‑2‑yl)‑2,5 diphenyl tetrazolium bromide (MTT) assay. 
Briefly, the cells were seeded in 96‑well tissue culture plates and 
incubated with increasing concentrations of each compound (10, 
20, 30, 40, 50, 60, and 70 μg/ml) for 24 h. Twenty microliters of 
MTT in phosphate‑buffered saline (PBS; 5 mg/ml) was then added 
to each well. Following a 4‑h incubation at 37°C, the medium/
MTT mixtures were removed and the blue insoluble formazan 
product formed by living cells was dissolved in dimethyl sulfox‑
ide (DMSO) (200 μl/well). The optical density of the wells was 
then measured with a microplate reader at 570 nm. All tests were 
performed in triplicate and the 50% inhibitory concentrations (IC50) 
were calculated from concentration–effect curves by interpolation.
Cellular Dox accumulation was determined as described 
by Huang and Liu.[13] In brief, MCF‑7/Dox cells in exponential 
growth were exposed to 10 μM doxorubicin in the absence or 
presence of conferone, mogoltacin, and feselol at 10 and 25 μM 
or verapamil (VPM; Sigma) at 10 μM for 3 h. Then the cells were 
harvested by centrifugation and rinsed with PBS. Cell pellets 
were suspended in 0.3 μM HCl in 50% ethanol and sonicated 
in an ultrasonic disintegrator for 30 s. Following centrifugation 
at 1500 g for 15 min, the supernatant was removed and assayed 
spectrofluorometrically for Dox content at excitation and emission 
wavelengths of 470 nm and 585 nm, respectively. The intracellular 
Dox content was calibrated with a standard curve of Dox and was 
expressed in picomoles per 106 cells.
Statistical analysis
Statistical analyses were performed using the SPSS (version 
11.0) software. Statistical comparison between groups was made 
by Student’s t‑test and one‑way analysis of variance (ANOVA) 
with Tukey–Kramer, a post‑hoc test. A P < 0.05 was considered to 
be statistically significant.
RESULTS AND DISCUSSION
Silica gel column chromatography of the dichloromethane 
extract of fruits of F. gummosa followed by preparative TLC re‑
sulted in three sesquiterpene coumarins including conferone (1), 
mogoltacin (2), and feselol (3), as reported in an earlier study.[11] 
The isolated coumarins [Figure 1] were identified by comparison 
of their NMR, mass spectrometry (MS), and melting point data 
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with those previously described in the literature.[5,14,15] Briefly, 
the structure of 1 was established from analysis of the 1H and 13C 
NMR spectra [Tables 1 and 2]. Compound 1 displayed 24 carbon 
signals, with 9 being typical of an umbelliferone skeleton and the 
other 15 signals were ascribable to a sesquiterpene moiety. The 
downfield signal at dC 161.5 was assigned to the carbonyl carbon 
Figure 1. Chemical structures of the compounds isolated from Ferula gummosa fruits conferone (1), mogoltacin (2) and feselol (3) and the structure 
of diportlandin (4)
Table 1. 1H‑NMR data obtained with compounds 1‑5 (600 MHz, δ ppm)*
5 (J)4 (J)3 (J)2 (J)1 (J)Position of proton
‑‑‑‑‑2
6.25 d (9.5)6.30 d (9.5)6.27 d (9.5)6.27 d (9.5)6.28 d (9.6)3
7.65 d (9.5)7.67 d (9.5)7.66 d (9.5)7.66 d (9.5)7.66 d (9.6)4
7.39 d (8.4)7.39 d (8.4)7.39 d (8.4)7.38 d (8.4)7.39 d (8.4)5
6.83 d (8.4)6.87 dd (8.4, 1.8)6.88 dd (8.4, 2.3)6.86 dd (8.4, 2.3)6.86 dd (8.4, 2.3)6
‑‑‑‑‑7
6.82 brs6.86 d (1.8)6.85 d (2.3)6.85 d (2.3)6.85 d (2.3)8
‑‑‑‑‑9
‑‑‑‑‑10
 1.55 ddd (15.0, 6.0, 6.0) β
1.97 dt (15.0, 4.2) α
1.68 m β
2.01 m α
1.37 dd (13.2, 4.2) β
2.05 m* α
1.75 m* β
2.01 m* α
1.66 dd* β
2.30 m α
1′
1.69 m1.70 m β
2.00 m α
1.67 m1.69 m2.31 m β
2.75 ddd (15.3, 6.6) α
2′
3.23 dd (10.8, 4.2)3.41 brs3.31 brd (10.8)3.52 brs‑3′
‑‑‑‑‑4′
2.16 s2.67 s1.30 dd (11.4, 6.0)1.73 dd*1.68 dd*5′
‑‑2.01 m*2.0 m*2.00 like brd β
2.18 like brt α 
6′
5.89 s5.93 brs5.60 brs5.59 brs5.62 brs7′
‑‑‑‑‑8′
2.66 brs2.81 brs2.26 brs2.37 brs2.28*9′
‑‑‑‑‑10′
a 4.14 dd (9.60, 5.40)
b 4.25 dd (9.60, 3.00)
a 4.18 dd (10.20, 5.40)
b 4.29 dd (10.20, 3.00)
a 4.03 dd (9.60, 5.40)
b 4.19 dd (9.60, 3.00)
a 4.04 dd (9.60, 6.00)
b 4.20 dd (9.60, 3.30)
a 4.10 dd (9.80, 5.20)
b 4.21 dd (9.80, 4.80)
11′
1.95 s1.99 s1.73 s1.73 s1.75 s12′
1.17 s1.23 s1.05 s1.02 s1.17 s13′
1.27 s1.26 s0.93 s0.97 s1.13 s14′
1.02 s1.07 s0.95 s0.96 s1.18 s15′
*Overlapped with other signals
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of the coumarin moiety, whereas the downfield signal at dC 216.4 
was indicative of a ketone group belonging to the sesquiterpene 
unit. HSQC spectrum classified the carbon signals to four aliphatic 
methylenes at dC 38.8 (C‑1′), 34.8 (C‑2′), 24.3 (C‑6′), and a pri‑
mary alcoholic carbon at dC 67.0 characteristic for C‑11′ and nine 
methines, five of them for umbelliferone moiety at dC 113.4 (C‑3), 
143.7 (C‑4), 129.2 (C‑5), 113.6 (C‑6), and 101.7 (C‑8) and four 
for methyls at dC 25.6 (C‑12′), 22.7 (C‑13′), 25.6 (C‑14′), and 
14.9 (C‑15′). The 1H NMR spectrum of 1 showed resonance char‑
acteristics of four methyl singlets at dH 1.75 (H‑12′), 1.17 (H‑13′), 
1.13 (H‑14′), and 1.18 (H‑15′) and three olefinic resonances at dH 
6.28 (H‑3), 7.66 (H‑4), and 5.62 (H‑7′). Three aromatic protons at 
dH 7.39 (H‑5), 6.86 (H‑6), and 6.85 (H‑8) suggested the presence 
of a 7, 9, 10‑trisubstituted benzene ring, which was supported 
by the 13C NMR spectrum [Tables 1 and 2 and Figures 2 and 3].
The NMR spectral data of 2 were similar to those of 1, except 
a slight difference in the signals assigned to the sesquiterpene unit 
which was due to the replacement of the ketone group at C‑3′ 
with an oxymethine. Regarding this portion and with respect to 
conferone, HMBC spectrum showed the correlations of the sec‑
ondary alcoholic H‑3′ (dH 3.52) to dC 25.2 (C‑2′), dC 37.6 (C‑4′), 
and to dC 43.8 (C‑5′). Other NMR spectral data of 2 were closely 
comparable to those of 1. Hence, the structure of 2 was determined 
as mogoltacin (or conferol) [Tables 1 and 2 and Figures 4 and 5].
The NMR spectral data of 3 were very similar to those of 
2, except for the stereochemistry of C‑3′. Thus, the differences 
between the 1H NMR of 2 and 3 appeared in the signals due to 
protons on C‑2′, C‑3′ and the methyl groups of 13′ and 14′. In 3, 
the signals for the H‑2′ and H‑3′ appeared at dH 1.67 and dH 3.31, 
respectively, and those for the methyl groups of 13′ and 14′ ap‑
peared at dH 1.05 and 0.93, respectively. In 2, the corresponding 
signals appeared at dH 1.69 (H‑2′), 3.52 (H‑3′), 1.02 (H‑13′), and 
0.97 (H‑14′), respectively. ROESY experiments confirmed the 
stereochemistry of 3′‑OH as β and α conformers for compounds 
2 and 3, respectively. Therefore, compound 3 was determined as 
feselol [Tables 1 and 2 and Figures 6 and 7].
Table 2. 13C‑NMR data obtained with compounds 1–5 
(125.7 MHz, δ ppm)
54321Position of carbon
160.9160.6161.6161.6161.52
113.3112.9113.4113.4113.43
143.3142.9143.8143.8143.74
128.8128.9129.1129.1129.25
112.6112.8113.5113.5113.66
161.2161.1162.4162.5162.27
101.1101.5101.7101.7101.78
155.6155.3156.3156.3156.39
112.7112.7112.9112.8113.010
37.331.138.232.238.81′
26.024.427.725.234.82′
78.576.179.276.2216.43′
37.636.339.137.647.94′
62.057.149.743.851.55′
198.4199.823.723.624.36′
129.5129.6124.1124.2124.07′
155.5155.3132.7132.9132.78′
54.754.854.253.953.49′
41.941.636.236.036.210′
65.365.967.467.567.011′
21.321.622.022.125.612′
14.821.428.428.522.713′
28.228.115.322.725.614′
15.516.115.215.214.915′
Figure 2. The 1H‑NMR spectrum of conferone (1)
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Based on a previous report on the P‑gp inhibitory effect of 
diportlandin [4 in Figure 1], a sesquiterpene coumarin from 
Euphorbia portlandica,[3] and conferone (1),[4] we decided to test 
the activity of conferone, feselol, and mogoltacin on doxorubicin 
uptake in MCF‑7/Dox cells. It should be pointed out that all of the 
tested compounds in this study and the previous one[3] contain a 
drimane‑type sesquiterpene moiety linked to 7‑hydroxycoumarin 
or 7‑hydroxycoumarin derivatives.
Although breast cancer cells are usually sensitive to che‑
motherapy, P‑gp overexpression and consequent resistance to 
chemotherapy is commonly observed in advanced breast tumors. 
Cells overexpressing P‑gp are characterized by a lower capac‑
Figure 3. The 13C‑NMR spectrum of conferone (1)
Figure 4. The 1H‑NMR spectrum of mogoltacin (2)
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ity to accumulate and retain anticancer drugs than the sensitive 
ones. Three hours after exposure to Dox, the MCF‑7/Dox cells 
showed an intracellular concentration of Dox 12.1‑fold lower 
than the parent sensitive MCF‑7 cells. This marked difference 
in the intracellular Dox content demonstrates the overexpres‑
sion of resistant human breast cancer cell line in drug efflux 
pumps. In a previous study, it was shown that diportlandin (4), 
a sesquiterpene coumarin with structural similarity to those of 
our tested compounds, has significant effect in inhibiting the 
efflux pump activity mediated by P‑gp, as compared to the 
positive control VPM.[3] In 2006, Barthomeuf et al. reported 
that conferone (1) enhances the uptake of vinblastine in a 
mammalian cell line expressing the MDR1 gene, evidencing 
for the first time that certain sesquiterpene ethers from Ferula 
may have some potency for the treatment of MDR malignan‑
cies.[4] Furthermore, it was observed that the ability to inhibit 
P‑gp transport is a common feature of various sesquiterpene 
coumarins from Ferula and that conferone may modulate MDR1 
Figure 5. The 13C‑NMR spectrum of mogoltacin (2)
Figure 6. The 1H‑NMR spectrum of feselol (3)
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gene expression.[16] In the present study, it was verified that 3 
h of exposure to feselol, mogoltacin, and conferone at 10 and 
25 μM, or to 10 μM VPM singly, was not toxic for MCF‑7 and 
MCF‑7/Dox. Exposure of MCF‑7/Dox to feselol, mogoltacin, 
conferone, or VPM enhanced Dox uptake [Figure 8]. This find‑
ing probably demonstrates that the tested coumarins have the 
capacity to inhibit P‑gp–mediated drug efflux in human breast 
cancer cells. The chemosensitizing effects of coumarin deriva‑
tives were dose dependent, but varied with the structure of the 
chemical. At 25 μM, all coumarins restored at least 50% of the 
reference uptake (uptake by sensitive cells); but at 10 μM, their 
potency varied in the order of conferone > mogoltacin > feselol. 
At this concentration, all compounds were less potent than the 
positive control. In sensitive MCF‑7 cells, the uptake of Dox 
by cells was not affected by the addition of coumarins at 10 
μM concentration. However, it was decreased by VPM at 10 
μM and by the coumarins at 25 μM. This decrease may be due 
to the enhanced cytotoxicity of the combination in sensitive 
MCF‑7 cells, which caused less cell density and, therefore, less 
intracellular Dox to be assayed [Figure 2].
The present study probably proves that conferone, mogoltacin, 
and feselol suppress P‑gp–mediated drug efflux in highly resistant 
human breast cancer cells. The most interesting finding is the 
possibility to establish the first structure–activity relationship, 
since all of the mentioned compounds have an identical carbon 
skeleton in their structures. On the other hand, previous findings[4,9] 
demonstrate that drimane‑type sesquiterpene coumarins have low 
toxicity and could serve as promising lead compounds for design‑
ing novel chemosensitizing agents. Although the toxicological 
profile of the tested phytochemicals is yet to be determined, it 
should be pointed out that Ferula species which contain these 
compounds have been traditionally used as medicinal plants, 
spices, and foods for a long time and, thus, could be considered 
as potentially safe.
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Figure 8. Enhanced accumulation of Dox in MCF‑7/Dox cells by 
conferone, feselol, mogoltacin, and VPM. MCF‑7/Dox (dark) and sensitive 
MCF‑7 (light) cells were incubated with Dox (10 μM) in the presence of 
the indicated concentrations of feselol, mogoltacin, and conferone. Control 
cells were not incubated with any compound. VPM (10 μM) was used as 
positive control. Each experiment was performed in triplicate. P‑values 
refer to the comparison between each tested compound and the negative 
control group. *P < 0.05; ***P < 0.001
Figure 7. The 13C‑NMR spectrum of feselol (3)
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